Reduction of postischemic myocardial dysfunction by substrate repletion during reperfusion

Area of Science:

• Cardiovascular Research
• Biochemistry
• Ischemic Heart Disease

Background:

• Normothermic ischemia leads to myocardial dysfunction and ATP depletion.
• Reperfusion strategies aim to restore cardiac function and energy levels.
• Metabolic substrates may play a crucial role in myocardial recovery.

Purpose of the Study:

• To investigate the impact of selected metabolic substrates on myocardial function and ATP recovery post-ischemia.
• To evaluate the efficacy of glutamate and ribose in enhancing recovery during reperfusion.

Main Methods:

• Thirty dogs underwent 45 minutes of normothermic global ischemia followed by 90 minutes of reperfusion.
• Hearts were randomized into five groups receiving different reperfusate solutions, including controls and those with potassium-blood cardioplegic solution (KBC) supplemented with glutamate, adenosine/EHNA, or ribose.
• Left ventricular function and ATP concentration were measured before, during, and after ischemia/reperfusion.

Main Results:

• KBC alone showed limited functional recovery compared to control.
• Glutamate significantly improved functional recovery by replenishing Krebs cycle intermediates.
• Ribose, combined with glutamate, further enhanced functional recovery and ATP levels, indicating improved purine salvage.
• Adenosine with EHNA initially depressed recovery but improved over time.

Conclusions:

• Selective substrate repletion during initial reperfusion is effective in improving myocardial function and ATP concentration after normothermic ischemia.
• Glutamate and ribose are key substrates that promote recovery by supporting energy metabolism and purine salvage pathways.
• Targeted metabolic interventions during reperfusion offer a promising strategy for mitigating ischemic injury.